REFERENCE LIBRARY / Shroomery
Re: An Introduction to our Psychedelic Medicine, Research & Microdosing Forum
本条目为第三方公开资料的归档，仅用于学术研究与科普，不构成任何操作指导或医学建议；物质处理涉及法律与健康风险，请在专业、合法的条件下自行核验。
正文中文为机器翻译，仅供参考；专业内容以折叠的原文为准。
每日微剂量给药存在心脏纤维化和瓣膜病的风险。四开三关可能更安全。但如果您正在服用另一种针对该受体的药物，或者已经患有心脏病，那么风险会更高。 LSD 具有更长的半衰期和更强的结合功效，比裸盖菇素/裸盖菇素带来的风险更大。 [引用块未复制，请查看原帖] https://journals.sagepub.com/do i/full/10.1177/02698811231225609
查看原文
There are risks of cardiac fibrosis and valvulopathy associated with microdosing daily. Four on and three off is likely safer. But if you're taking another medication that targets this receptor, or have a heart condition already, the risks would be higher. And LSD, with its longer half-life and greater binding efficacy, would pose an even larger risk than psilocybin/psilocin. [引用块未复制，请查看原帖] https://journals.sagepub.com/do i/full/10.1177/02698811231225609
来源与许可
Shroomery · 社区讨论
原创帖子 CC BY-NC-SA 4.0（非商业、署名、相同方式共享）；本库仅保存纯文本，未复制引用块、图片、附件与签名。